spacer
home > pmps > spring 2017 > packaging for people
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Packaging for People

Developments in Europe since the first EU legislation in 1992 have led to a substantial standardisation of medicinal packaging. The law demands a combination of outer packaging, an inner container and a leaflet, and most drugs across Europe are now packed in a very similar way. This, of course, has major benefits for the pharmaceutical trade and for regulatory controls as it is relatively easy to compare prices and check legal compliance.

However, the perspective of the actual user is rarely considered. One reason might be that this point of view is more difficult to quantify and control. There are different ways in which drugs can be obtained (with or without a prescription) and numerous situations in which they are used (home, hospital, emergency). They are handled by several different people (healthcare professionals, carers, patients), all of whom differ in age, experience, language and reading abilities. Until now, this variety has been almost completely ignored in the packaging designs – there is only a ‘one-size-fits-all’ standard.

A second reason that the user perspective has not attracted much attention might be that production developments and continuous modifications to the regulations about packaging and leaflets has demanded most of the time and effort. There is rarely any time to consider what the consequences of legal compliance are on the people who handle medicines in care situations.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Karel van der Waarde is a researcher and consultant for Graphic Design- Research, a company that writes, designs and tests packaging, package inserts and visual information about medicines. The focus is on a direct cooperation with people to develop digital formats and tangible instructions on labels, packaging and inserts. He holds a PhD from Reading University, UK, and has worked in the pharmaceutical industry ever since.
spacer
Dr Karel van der Waarde
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Prometic Bioseparations are very pleased to introduce their new purpose built ecommerce platform (Webshop)!

Their goal was to build a platform that is easy to navigate, informative and one that makes their products and services easily accessible to researchers and laboratories worldwide. They also wanted to make ordering as quick and easy as possible to meet the needs of the rapidly progressive industry. They have reflected these requirements with an ecommerce store in order to supply high quality products to customers from academia to big pharma.
More info >>

White Papers

Microalgae Culture Using the DASGIP® PBR4 Module for Illumination with a New Brunswick™ CelliGen® 310 Stirred-tank Bioreactor

Eppendorf

The number of bioprocess applications for microalgae has increased in recent years, particularly in the fi eld of biofuel production. The combination of the New Brunswick CelliGen 310 stirred-tank bioreactor and the DASGIP LED Illumination System creates a bioreactor setup which is capable of supporting high density microalgal growth. Using the stand-alone Eppendorf DASGIP PBR4 Module, LED illumination spectra and intensities can be controlled for optimal support of all types of chlorophylls and carotenoids. For this study in which high density culture of up to 1.5 x 107 cells/mL was achieved, the unicellular freshwater alga, Dunaliella tertiolecta, was used.
More info >>

 
Industry Events

BioTrinity 2018

23-25 April 2018, Novotel London West in Hammersmith

BioTrinity 2018 is taking place from 23-25 April at the Novotel London West in Hammersmith. Now in its 12th year, BioTrinity remains the leading life sciences biopartnering and investment conference in Europe, and is a must attend event for R&D companies, TTO’s and academia who are looking to meet, collaborate, partner and seek funding from Big Pharma, Investors and Associated Industry companies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement